Early Insights Into Home OCT Monitoring Reveal Real-World Impact
In our conversation, which has been edited for length and clarity, Kapil Kapoor, MD, a vitreoretinal surgeon and president of research at the Wagner Kapoor Institute, discussed the reasons his practice was an early adopter of home OCT and described the experiences of implementing the program for both patients and team members.
Clinical Scorecard: Early Insights Into Home OCT Monitoring Reveal Real-World Impact
At a Glance
Category Detail
Condition Neovascular Age-Related Macular Degeneration (nAMD) Key Mechanisms Home OCT monitoring for continuous data collection and evaluation of retinal hyporeflective spaces. Target Population Patients with nAMD, particularly those in rural areas or with limited mobility. Care Setting Home-based diagnostics integrated into clinical practice.
Key Highlights
FDA approved the Scanly home OCT device for nAMD in May 2024. Home monitoring reduces patient burden and enhances timely clinical decision-making. Patients reported high satisfaction and ease of use with the home OCT device. Continuous data collection allows for better management of disease activity. Early detection of fluid can prevent vision loss. Guideline-Based Recommendations
Diagnosis
Utilize home OCT to monitor retinal changes in nAMD patients. Management
Implement home OCT as part of routine care for nAMD to enhance patient outcomes. Monitoring & Follow-up
Track volume of hyporeflective spaces over time to assess treatment response. Risks
Address potential patient anxiety regarding new technology and ensure proper training. Patient & Prescribing Data
Patients with nAMD, especially those in remote locations.
Home OCT monitoring can lead to extended follow-up intervals and improved patient confidence.
Clinical Best Practices
Designate a team member to support patients in using the home OCT device. Treat home OCT integration as a clinical trial to streamline processes. Encourage patient feedback to improve the adoption of home monitoring. Related Resources & Content
